Atopic eczema/dermatitis (non-specific)

Clinical trials for Atopic eczema/dermatitis (non-specific) explained in plain language.

Never miss a new study

Get alerted when new Atopic eczema/dermatitis (non-specific) trials appear

Sign up with your email to follow new studies for Atopic eczema/dermatitis (non-specific), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

New eczema drug ATTO-3712 enters early human safety trials

Symptom relief Completed

This early-stage study tests a new drug called ATTO-3712 in healthy adults and people with atopic dermatitis (eczema). The main goal is to check if the drug is safe and how the body processes it. Participants receive either the drug or a placebo and are monitored with clinic visi…

Matched conditions: ATOPIC ECZEMA/DERMATITIS (NON-SPECIFIC)

Phase 1 • Sponsor: Attovia Therapeutics Inc • Aim: Symptom relief

Last updated Sep 13, 2026 00:00 UTC

Atopic eczema/dermatitis (non-specific)

Get alerted when new Atopic eczema/dermatitis (non-specific) trials appear

New eczema drug ATTO-3712 enters early human safety trials